[Congenital Long QT Syndrome]

Overview

Journal Arch Peru Cardiol Cir Cardiovasc

Specialty Cardiology & Vascular Diseases

Date 2023 Sep 20

PMID 37727265

Authors

Luis Alfredo Melgar Quicano

Fredy Chipa Ccasani

Affiliations

Soon will be listed here.

Abstract

Congenital long QT syndrome (LQTS) represents a group of heart diseases of genetic origin characterized by prolongation of the QT interval and an abnormal T wave on the electrocardiogram (ECG). They can have a dominant or recessive expression, the latter associated with sensorineural deafness. In both cases, its clinical presentation is associated with recurrent syncope and sudden death as a consequence of ventricular tachycardia, specifically Torsades de Pointes. Currently they are classified according to the specific genetic defect, being able to compromise around 16 genes and almost 2000 mutations. It should be suspected in individuals with related symptoms, electrocardiographic findings, and family history. Management is based on the reduction or elimination of symptoms, and concomitantly the prevention of sudden death (SD), in those children with congenital deafness, the management requires the application of the otolaryngologist specialist's own measures. The cardiovascular management implies the modification of lifestyles, mainly the prohibition of competitive sports, including swimming, avoiding exposure to loud sounds or triggers. The medications used include beta-blockers, and more rarely flecainide, ranozaline, and verapamil; invasive management consists of the implantation of a cardioverter defibrillator or even left sympathetic denervation, each with its own risks and benefits. In any of the cases, we must avoid the circumstances that increase the QT interval, as well as carry out the appropriate analysis of the benefits and risks of each possible invasive measure.

References

Jazayeri M, Emert M . Sudden Cardiac Death: Who Is at Risk?. Med Clin North Am. 2019; 103(5):913-930. DOI: 10.1016/j.mcna.2019.04.006. View

Waddell-Smith K, Skinner J . Update on the Diagnosis and Management of Familial Long QT Syndrome. Heart Lung Circ. 2016; 25(8):769-76. DOI: 10.1016/j.hlc.2016.01.020. View

Garson Jr A, Dick 2nd M, Fournier A, Gillette P, Hamilton R, Kugler J . The long QT syndrome in children. An international study of 287 patients. Circulation. 1993; 87(6):1866-72. DOI: 10.1161/01.cir.87.6.1866. View

Baltogiannis G, Conte G, Sieira J, De Ferrari G, Brugada P . Editorial: Sudden Cardiac Death and Channelopathies. Front Cardiovasc Med. 2020; 7:605834. PMC: 7723825. DOI: 10.3389/fcvm.2020.605834. View

Lahrouchi N, Tadros R, Crotti L, Mizusawa Y, Postema P, Beekman L . Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome. Circulation. 2020; 142(4):324-338. PMC: 7382531. DOI: 10.1161/CIRCULATIONAHA.120.045956. View

Sepp R, Hategan L, Bacsi A, Cseklye J, Kornyei L, Borbas J . Timothy syndrome 1 genotype without syndactyly and major extracardiac manifestations. Am J Med Genet A. 2017; 173(3):784-789. DOI: 10.1002/ajmg.a.38084. View

Extramiana F, Maison-Blanche P, Badilini F, Pinoteau J, Deseo T, COUMEL P . Circadian modulation of QT rate dependence in healthy volunteers: gender and age differences. J Electrocardiol. 1999; 32(1):33-43. DOI: 10.1016/s0022-0736(99)90019-5. View

Munoz-Esparza C, Zorio E, Domingo Valero D, Penafiel-Verdu P, Sanchez-Munoz J, Garcia-Molina E . Value of the "Standing Test" in the Diagnosis and Evaluation of Beta-blocker Therapy Response in Long QT Syndrome. Rev Esp Cardiol (Engl Ed). 2017; 70(11):907-914. DOI: 10.1016/j.rec.2017.01.006. View

Wallace E, Howard L, Liu M, OBrien T, Ward D, Shen S . Long QT Syndrome: Genetics and Future Perspective. Pediatr Cardiol. 2019; 40(7):1419-1430. PMC: 6785594. DOI: 10.1007/s00246-019-02151-x. View

10.

Chorin E, Hu D, Antzelevitch C, Hochstadt A, Belardinelli L, Zeltser D . Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data. Circ Arrhythm Electrophysiol. 2016; 9(10). PMC: 5119553. DOI: 10.1161/CIRCEP.116.004370. View

11.

Asakai H, Shimizu A, Mitsuhashi T, Ueyama T, Yokoshiki H, Nishii N . Current Trends in Implantable Cardioverter-Defibrillator Therapy in Children　- Results From the JCDTR Database. Circ J. 2018; 83(1):52-55. DOI: 10.1253/circj.CJ-18-0712. View

12.

Lewandowski M, Syska P, Kowalik I, Maciag A, Sterlinski M, Atenska-Pawlowska J . Fifteen years' experience of implantable cardioverter defibrillator in children and young adults: Mortality and complications study. Pediatr Int. 2018; 60(10):923-930. DOI: 10.1111/ped.13660. View

13.

Li K, Yang J, Guo W, Lv T, Guo J, Li J . Video-Assisted Thoracoscopic Left Cardiac Sympathetic Denervation in Chinese Patients with Long QT Syndrome. Int Heart J. 2018; 59(6):1346-1351. DOI: 10.1536/ihj.17-727. View

14.

Kukla P, Biernacka E, Baranchuk A, Jastrzebski M, Jagodzinska M . Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome. Curr Cardiol Rev. 2014; 10(3):222-8. PMC: 4040873. DOI: 10.2174/1573403x10666140514102528. View

15.

Biton Y, Rosero S, Moss A, Goldenberg I, Kutyifa V, McNitt S . Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients. Europace. 2018; 21(2):339-346. PMC: 6365807. DOI: 10.1093/europace/euy149. View

16.

Perez-Riera A, Barbosa-Barros R, Raimundo R, da Costa de Rezende Barbosa M, Sorpreso I, de Abreu L . The congenital long QT syndrome Type 3: An update. Indian Pacing Electrophysiol J. 2017; 18(1):25-35. PMC: 5840852. DOI: 10.1016/j.ipej.2017.10.011. View

17.

Cobos Gil M, Garcia Rubira J . Who was the creator of Bazett's formula?. Rev Esp Cardiol. 2008; 61(8):896-7. View

18.

Viskin S, Postema P, Bhuiyan Z, Rosso R, Kalman J, Vohra J . The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 2010; 55(18):1955-61. PMC: 2862092. DOI: 10.1016/j.jacc.2009.12.015. View

19.

Haag M, Hersh A, Toffey D, Sargent J, Stecker E, Heitner S . Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Children with Cardiac Conditions Associated with Risk for Sudden Cardiac Death. Pediatr Cardiol. 2020; 41(7):1484-1491. DOI: 10.1007/s00246-020-02395-y. View

20.

Faridi R, Tona R, Brofferio A, Hoa M, Olszewski R, Schrauwen I . Mutational and phenotypic spectra of KCNE1 deficiency in Jervell and Lange-Nielsen Syndrome and Romano-Ward Syndrome. Hum Mutat. 2018; 40(2):162-176. PMC: 6328321. DOI: 10.1002/humu.23689. View